The LEAP2 gene helps make a small protein, mainly in the liver and gut, that puts a brake on ghrelin, the hormone that signals hunger. This helps your body balance appetite, body weight, blood sugar, and some growth hormone activity. Differences in this gene can help explain why people feel hungrier or gain weight more easily, although many variants are harmless. If the gene does not work well, hunger signals may be less controlled, and rare disruptive variants have been linked to severe early weight gain.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes hold the directions for making proteins, which are the working parts of cells. Other genes mainly control when certain processes take place, where they happen, and how strongly they run. As a group, genes influence how the body develops and functions, and they can also affect how you respond to food, stress, or medications. If you want to explore this subject in greater depth, you can read more in the LearnHub.
Overview
LEAP2Gene function
What if the gene works
The LEAP2 gene helps make a small protein that balances the hunger signal ghrelin. It is made mainly in the liver and gut and also supports defense against some microbes.
Risk
What if the gene does not work
Milder to more severe variants in the LEAP2 gene can reduce or alter the LEAP2 peptide, which normally helps restrain ghrelin signaling (cell messages from a hunger hormone). This may weaken cellular signaling control.
Treatment
What does that mean for your treatment
No LEAP2-specific treatment or management approach is currently established for people with a pathogenic variant in the LEAP2 gene. Researchers are studying LEAP2 as a possible biomarker and drug target in obesity and metabolic disease, but this has not changed routine care.
Gene function
What if the gene works
The LEAP2 gene helps your body fine tune hunger signals, energy use, and blood sugar balance. It does this by making a small protein that slows one of the body’s main hunger pathways, centered on the ghrelin receptor (the receptor that receives hunger signals). This is part of how the LEAP2 gene helps control appetite and metabolism in daily life.
The LEAP2 gene makes a protein that attaches to the ghrelin receptor, the receptor that receives hunger signals. This acts like a natural brake and helps keep appetite signaling in balance.
LEAP2 helps your body adjust hunger cues to its current energy state, such as between fasting and eating. This supports a more coordinated link between food intake and energy needs.
By shaping ghrelin signaling, the LEAP2 gene also supports normal glucose control. This connects appetite regulation with the way your body manages energy after and between meals.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can affect how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the LEAP2 gene can change the shape of its small protein product, how stably it is made, and how well it is released from cells or binds to its usual cell target. In descriptions of how LEAP2 gene variants affect protein function, milder variants may only partly reduce stability or binding, while more severe variants can sharply lower the amount of usable protein or stop it from working at all. This creates a spectrum of functional impact rather than one fixed effect.
How variants are linked to conditions
Research on LEAP2 gene variants and health conditions is still developing, and no single LEAP2-related condition has broad confirmation across major medical genetics references. Anyone with a confirmed variant in the LEAP2 gene should rely on guidance from their doctor or genetic counselor for interpretation in the context of their own health and family history.
A variant is not necessarily a diagnosis
Genetic variants are a common and normal feature of human biology. Most do not directly affect health and simply contribute to natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the LEAP2 gene. If a change in LEAP2 is found on genetic testing, a doctor or genetic counselor can help explain what it may mean in the context of personal and family history.
Inheritance of LEAP2 variants
There is not yet a broadly confirmed, disease-associated inheritance pattern for the LEAP2 gene, so answers about how LEAP2 gene variants are inherited remain limited to ongoing research rather than a settled dominant, recessive, or X-linked model. The LEAP2 gene is located on chromosome 5, which is an autosome. That means you inherit one copy of the LEAP2 gene from your mother and one copy from your father.
What does my LEAP2 result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific health condition for LEAP2, though this understanding can change as research develops. If you have a specific LEAP2 result and questions about what it could mean for your family, a doctor or genetic counselor can explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
To learn how genetic testing finds LEAP2 gene variants, a lab reads DNA from a blood or saliva sample and compares the LEAP2 gene sequence with a reference sequence. The report lists any variants found and notes whether they are well understood or need more interpretation.
When should I consider getting a genetic test?
There is not yet a broadly established reason to do routine testing for changes in the LEAP2 gene. Testing decisions are usually guided by your symptoms, overall health, and family history, together with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals depends on the condition and the specific type of variant. Over time, many other factors also influence how the body functions, including lifestyle, environment, age, and medical history. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic information can also help make sense of a person’s individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug more quickly, while another may process the same drug more slowly or be more sensitive to its effects. These differences are common and can influence how well a treatment works or how likely someone is to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medications. It studies links between genes and drugs to understand why the same treatment can work differently in different people. For many medicines, genes can influence how the body handles a drug or how strong its effects are. This information can support more informed, more personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the LEAP2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or response, so questions about side effects, new symptoms, or how a treatment is working are best discussed with your doctor.
History
In the early 2000s, researchers identified the LEAP2 gene while studying small proteins made in the liver and small intestine. It was first described as part of the body’s natural defense system, based on its link to an antimicrobial peptide. Over time, scientists’ understanding of the gene’s function has changed. Building on this early work, scientists uncovered that LEAP2 also helps regulate appetite and energy balance by interacting with the same pathway as ghrelin, a hormone linked to hunger. That shift made LEAP2 more relevant beyond infection research and into metabolism studies. Today, its history reflects how a gene first noticed in one setting can later become important in a very different area of medicine.